Video with Prof. Dr. Jeroen Dekervel on the place of durvalumab in the treatment of biliary tract cancer

May 2023 Cancer trials Tom Feys

In this video, Prof. Dr. Jeroen Dekervel (University Hospitals Leuven) walks us through the results of the TOPAZ-1 study and discusses the position of durvalumab plus gemcitabine and cisplatin in the first-line treatment of biliary tract cancer.

NS ID XL-3361-Revision date 04/2023-LB